As of 2024-12-14, the Relative Valuation of Vicore Pharma Holding AB (VICO.ST) is (24.82) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 7.76 SEK, the upside of Vicore Pharma Holding AB based on Relative Valuation is -419.8%.
The range of the Relative Valuation is (15.69) - (26.69) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.4x - 31.3x | 31.0x |
| Forward P/E multiples | 16.3x - 34.3x | 27.2x |
| Fair Price | (15.69) - (26.69) | (24.82) |
| Upside | -302.2% - -444.0% | -419.8% |
| Date | P/E |
| 2024-12-11 | -9.10 |
| 2024-12-10 | -9.05 |
| 2024-12-09 | -8.97 |
| 2024-12-06 | -9.06 |
| 2024-12-05 | -8.98 |
| 2024-12-04 | -9.00 |
| 2024-12-03 | -8.83 |
| 2024-12-02 | -8.91 |
| 2024-11-29 | -9.19 |
| 2024-11-28 | -9.61 |
| 2024-11-27 | -9.20 |
| 2024-11-26 | -9.10 |
| 2024-11-25 | -9.03 |
| 2024-11-22 | -9.27 |
| 2024-11-21 | -9.12 |
| 2024-11-20 | -9.11 |
| 2024-11-19 | -8.86 |
| 2024-11-18 | -8.93 |
| 2024-11-15 | -8.92 |
| 2024-11-14 | -9.36 |
| 2024-11-13 | -9.60 |
| 2024-11-12 | -9.40 |
| 2024-11-11 | -9.47 |
| 2024-11-08 | -9.52 |
| 2024-11-07 | -9.56 |
| 2024-11-06 | -9.32 |
| 2024-11-05 | -9.38 |
| 2024-11-04 | -9.32 |
| 2024-11-01 | -9.38 |
| 2024-10-31 | -9.38 |
| 2024-10-30 | -9.64 |
| 2024-10-29 | -9.65 |
| 2024-10-28 | -9.71 |
| 2024-10-25 | -9.70 |
| 2024-10-24 | -9.84 |
| 2024-10-23 | -10.08 |
| 2024-10-22 | -10.24 |
| 2024-10-21 | -10.13 |
| 2024-10-18 | -10.11 |
| 2024-10-17 | -10.75 |
| 2024-10-16 | -10.47 |
| 2024-10-15 | -9.87 |
| 2024-10-14 | -9.93 |
| 2024-10-11 | -9.78 |
| 2024-10-10 | -9.51 |
| 2024-10-09 | -9.94 |
| 2024-10-08 | -10.13 |
| 2024-10-07 | -8.92 |
| 2024-10-04 | -9.09 |
| 2024-10-03 | -8.79 |